<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Otolaryngology–Head &amp; Neck Surgery Online First</title>
    <link>http://archotol.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Thu, 16 May 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Thu, 16 May 2013 15:43:19 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archotol.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archotol.jamanetwork.com</webMaster>
    <item>
      <title>An Oral Cavity Carcinoma Nomogram to Predict Benefit of Adjuvant Radiotherapy Oral Cavity Adjuvant Radiotherapy Prediction Model </title>
      <link>http://archotol.jamanetwork.com/article.aspx?articleID=1686141</link>
      <pubDate>Thu, 16 May 2013 00:00:00 GMT</pubDate>
      <author>Wang SJ, Patel SG, Shah JP, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Importance&lt;/div&gt;After surgical resection for oral cavity squamous cell carcinoma, adjuvant radiotherapy may be recommended for patients at higher risk for locoregional recurrence, but it can be difficult to predict whether a particular patient will benefit.&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To construct a model to predict which patients with oral cavity squamous cell carcinoma would benefit from adjuvant radiotherapy.&lt;div class="boxTitle"&gt;Design and Setting&lt;/div&gt;We constructed several types of survival models using a set of 979 patients with oral cavity squamous cell carcinoma. Covariates were age, sex, tobacco use, stage, grade, margins, and subsite. The best performing model was externally validated on a set of 431 patients.&lt;div class="boxTitle"&gt;Participants&lt;/div&gt;The model was based on a set of 979 patients with oral cavity squamous cell carcinoma, including 563 from Memorial Sloan Kettering Cancer Center, New York, New York, and 416 from the Hospital AC Camargo, São Paulo, Brazil. The validation set consisted of 431 patients from Princess Margaret Hospital, Toronto, Ontario, Canada.&lt;div class="boxTitle"&gt;Main Outcome and Measure&lt;/div&gt;The primary outcome measure of interest was locoregional recurrence-free survival.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;The lognormal model showed the best performance per the Akaike information criterion. An online nomogram was built from this model that estimates locoregional failure-free survival with and without postoperative radiotherapy.&lt;div class="boxTitle"&gt;Conclusions and Relevance&lt;/div&gt;A web-based nomogram can be used as a decision aid for adjuvant treatment decisions for patients with oral cavity squamous cell carcinoma.&lt;/span&gt;</description>
      <prism:startingPage xmlns:prism="prism">1</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">6</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamaoto.2013.3001</prism:doi>
      <guid>http://archotol.jamanetwork.com/article.aspx?articleID=1686141</guid>
    </item>
    <item>
      <title>Learning Curve for Transoral Robotic Surgery A 4-Year Analysis  Learning Curve for Transoral Robotic Surgery </title>
      <link>http://archotol.jamanetwork.com/article.aspx?articleID=1686142</link>
      <pubDate>Thu, 16 May 2013 00:00:00 GMT</pubDate>
      <author>White HN, Frederick J, Zimmerman T, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Importance&lt;/div&gt;As new institutions incorporate transoral robotic surgery (TORS) into their everyday practice, it is helpful to have a timeline reference of expected goals to follow as their experience increases. This article evaluates a single tertiary care academic institution's experience with TORS for head and neck tumors and reports its 4-year learning curve.&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To evaluate a single institution's experience with TORS over a 4-year period and report treatment trends and clinical outcomes.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;Prospective case study.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;A single tertiary care academic institution.&lt;div class="boxTitle"&gt;Participants&lt;/div&gt;A total of 168 patients underwent TORS for tumors of the head and neck at University of Alabama at Birmingham between March 2007 and September 2011. The total group was subdivided into 4 consecutive groups (42 patients each). Patients were monitored throughout their hospital stay and up to 4.5 years postoperatively (mean follow-up duration, 14 months).&lt;div class="boxTitle"&gt;Intervention&lt;/div&gt;Transoral robotic surgery.&lt;div class="boxTitle"&gt;Main Outcomes and Measures&lt;/div&gt;Data points were collected and compared over time, including feasibility, operative time, tumor type, stage, subsite, length of intubation, need for tracheostomy, feeding tube use, hospital stay, margin status, neck dissection performed, and postoperative complications.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Significant decreases in operative time, length of intubation, and hospital stay were seen as TORS experience increased. Overall, the mean operative time decreased by 47% (group 4, 86 minutes; group 1, 183 minutes). Total mean intubation time decreased by 87% (group 1, 12.9 hours; group 4, 1.7 hours) and mean hospital stay decreased from 3.0 days to 1.4 days. There was not a significant difference between groups in number of cases unable to be performed robotically (7-9 per group), tumor stage (majority T1/T2), tumor subsite (majority oropharynx), positive margin status (2-5 per group), number of salvage cases performed (7-9 per group), and number of tracheostomies (2-4 per group) or feeding tubes (22-25 per group) required.&lt;div class="boxTitle"&gt;Conclusions and Relevance&lt;/div&gt;This is the first multiyear prospective study to document a single institution's TORS experience over time and demonstrate particular areas of expected improvement as case number increases.&lt;/span&gt;</description>
      <prism:startingPage xmlns:prism="prism">1</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">4</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamaoto.2013.3007</prism:doi>
      <guid>http://archotol.jamanetwork.com/article.aspx?articleID=1686142</guid>
    </item>
    <item>
      <title>Disinfection of Rigid Nasal Endoscopes Following In Vitro Contamination With  Staphylococcus aureus ,  Streptococcus pneumoniae ,  Pseudomonas aeruginosa , and  Haemophilus influenzae  Disinfecting Contaminated Rigid Nasal Endoscopes </title>
      <link>http://archotol.jamanetwork.com/article.aspx?articleID=1686143</link>
      <pubDate>Thu, 16 May 2013 00:00:00 GMT</pubDate>
      <author>Bradford BD, Seiberling KA, Park FE, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Importance&lt;/div&gt;If not adequately cleaned, rigid nasal endoscopes (RNEs) have the potential to cause iatrogenic cross-contamination.&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To test the efficacy of various disinfection methods in reducing bacterial load on RNEs in vitro.&lt;div class="boxTitle"&gt;Design and Setting&lt;/div&gt;In vitro model.&lt;div class="boxTitle"&gt;Interventions&lt;/div&gt;Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Haemophilus influenzae contamination was separately induced on RNEs in vitro. Two experimental sets were completed. The RNEs were disinfected using the following protocols: 30-second scrub with antimicrobial soap (ABS) and water, 30-second scrub with 70% isopropyl alcohol (IA), 30-second scrub with ABS followed by 30-second scrub with IA, 30-second scrub with germicidal cloth, isolated 5-minute soak in an enzymatic soap solution, 5- and 10-minute soaks in ortho-phthalaldehyde, 0.55%, solution (Cidex OPA), and isolated 30-second rinse with tap water, all with 30-second precleaning and postcleaning rinses with tap water. Two sets of experiments (experiment sets A and B) were carried out with a 30-second tap water rinse after inoculation of each RNE. This was followed by immediate cleaning in set A and a 1-hour air-dry delay in set B. Otherwise there were no differences in the disinfection protocols between sets for each method noted.&lt;div class="boxTitle"&gt;Main Outcomes and Measures&lt;/div&gt;Effectiveness of various disinfection protocols in cleaning rigid nasal endoscopes experimentally inoculated with bacteria commonly found in the upper aerodigestive tract. Positive cultures following disinfection indicated ineffective or incomplete disinfection.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Most cleaning methods were effective in eliminating S aureus, S pneumoniae, and H influenzae from the scopes following experimental contamination. Continued growth of P aeruginosa was found after all of the disinfection trials in experiment set A with the exception of a 10-minute immersion in Cidex OPA, and in set B except for the 10-minute Cidex OPA immersion and ABS plus IA trials.&lt;div class="boxTitle"&gt;Conclusions and Relevance&lt;/div&gt;Most cleaning methods used in our trials appear to properly disinfect RNEs after in vitro inoculation with S aureus, S pneumoniae, and H influenzae. However, it appears that disinfectants may be less effective in cleaning rigid scopes experimentally inoculated with P aeruginosa. There is a paucity of published data regarding cross-contamination during rigid nasal endoscopy, and these results should guide future studies and to some extent practice to avoid iatrogenic spread of contamination.&lt;/span&gt;</description>
      <prism:startingPage xmlns:prism="prism">1</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">5</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamaoto.2013.3016</prism:doi>
      <guid>http://archotol.jamanetwork.com/article.aspx?articleID=1686143</guid>
    </item>
  </channel>
</rss>